South Korea stock market fell due to profit-taking in tech and chemical sectors.
From NASDAQ.: 2025-01-12 17:59:32 The South Korea stock market ended a five-day winning streak, with the KOSPI falling 0.24% to
Category: Markets
Upstart stock jumped 51% in 2024, but company is still 85% off its highs.
From Nasdaq: 2025-01-12 17:15:45 Shares of Upstart (NASDAQ: UPST) stock surged 51% in 2024, but the AI credit evaluation company
Telix Pharmaceuticals acquires next-gen therapeutic assets and research facility from ImaginAb
From GlobeNewswire: 2025-01-12 17:04:58 Telix Pharmaceuticals Limited has entered into an asset purchase agreement with ImaginAb, Inc. to acquire a
Ascendis Pharma expects significant revenue growth with new medicines and strategic roadmap
From GlobeNewswire: 2025-01-12 17:00:00 Ascendis Pharma A/S is set for rapid revenue growth with the launch of two new medicines
Amicus Therapeutics reports strong revenue growth in 2024, expects further growth in 2025
From GlobeNewswire: 2025-01-12 16:00:00 Amicus Therapeutics reported a total revenue of $528.5 million in 2024, showing a significant 32% year-over-year
Scorpio Tankers Inc. plans to issue fixed income bonds for refinancing and general corporate purposes.
From GlobeNewswire: 2025-01-12 15:26:11 Scorpio Tankers Inc. will arrange investor calls for a possible fixed income bond issue to refinance
Positive. Guru Fundamental Report rates ACN highest using Growth Investor model based on Martin Zweig.
From NASDAQ.: 2025-01-12 15:00:00 Validea’s guru fundamental report for ACCENTURE PLC (ACN) shows that it rates highest using the Growth
RIGETTI COMPUTING INC (RGTI) rates highest in P/B Growth Investor model, but with some flaws.
From Nasdaq.: 2025-01-12 15:00:00 Validea’s guru fundamental report for RIGETTI COMPUTING INC (RGTI) shows it rates highest using the P/B
Nvidia grew to $3.4 trillion with focus on AI, projected to continue dominance in 2025
From Nasdaq: 2025-01-12 14:00:00 Nvidia (NASDAQ: NVDA) has seen exponential growth over the past two years, turning into a $3.4
Exagen receives conditional approval for new lupus and RA biomarker assays in New York.
From Nasdaq: 2025-01-12 13:04:51 Exagen Inc. has received conditional approval from the New York State Department of Health for its
Busy week ahead with earnings season starting and key economic data releases
From Barchart: 2025-01-12 13:00:02 Investors are gearing up for a busy week as the second full week of 2025 kicks
Molecular Partners updates Radio-DARPin programs, reports strong cash position; positive.
From GlobeNewswire: 2025-01-12 13:00:00 Molecular Partners has announced updates on its Radio-DARPin programs, including the entry of Radio-DARPin MP0712 targeting
Molecular Partners and Orano Med expand partnership adding six new therapy candidates
From GlobeNewswire: 2025-01-12 13:00:00 Molecular Partners and Orano Med have expanded their collaboration, adding six more targeted alpha therapy candidates
Average 401(k) balance for retirees age 65 and older is $272,588, with $88,488 median.
From Nasdaq: 2025-01-12 12:45:00 The 401(k) retirement account is a popular choice among Americans for saving and investing in retirement,
Exagen Inc. receives conditional NY State approval for new SLE and RA biomarker assays
From GlobeNewswire: 2025-01-12 12:00:00 Exagen Inc. announces conditional approval for new SLE and RA biomarker assays, set for commercial launch
MicroStrategy raises $500 million to buy more Bitcoin, sparking debate on investing in MSTR.
From Barchart: 2025-01-12 11:30:02 Bitcoin’s value continues to climb, reaching new highs as investor interest grows. MicroStrategy’s recent $500 million
Lucid Group (LCID) is a promising EV stock with room for growth and potential profitability.
From Nasdaq: 2025-01-12 11:20:00 Tesla, a trillion-dollar company, remains a solid investment, but identifying the next big EV stock like
Mereo BioPharma updates progress on Phase 3 studies for setrusumab and alvelestat
From GlobeNewswire: 2025-01-12 11:05:16 Mereo BioPharma continues Phase 3 study of setrusumab in osteogenesis imperfecta, with planned second interim analysis
Ultragenyx exceeded 2024 revenue guidance, expects continued growth in 2025
From GlobeNewswire: 2025-01-12 11:00:00 Ultragenyx Pharmaceutical Inc. reported preliminary unaudited 2024 revenue results exceeding guidance, with total revenue of $555
Mastercard Inc (MA) receives high rating for fundamentals and valuation using Warren Buffett's strategy
From Nasdaq MarketSite: 2025-01-12 11:00:00 Validea’s guru fundamental report for MASTERCARD INC (MA) shows that it rates highest using the
Ulta Beauty stock has appreciated 57.6% in 5 years, but underperformed S&P 500
From Nasdaq: 2025-01-12 10:00:00 Investors are focusing on future returns but looking at past stock performance can provide valuable insights.
Public Storage's stock dropped 30% despite sales growth, remains high-yield S&P 500 stock
From Nasdaq: 2025-01-12 09:30:00 Public Storage, a leading REIT, saw its share price double between 2020 and 2022 due to
TSM rates high in Twin Momentum Investor model for strong market outperformance potential.
From Nasdaq: 2025-01-12 09:00:00 Validea’s guru fundamental report for TAIWAN SEMICONDUCTOR MFG. CO. LTD. (TSM) shows that it rates highest
Arcutis Biotherapeutics expects significant revenue growth in Q4 and full-year 2024.
From GlobeNewswire: 2025-01-12 08:30:00 Arcutis Biotherapeutics, Inc. announced preliminary unaudited financial information for Q4 2024 and the full year. Q4
E Ink unveils Spectra 6 ePaper Retail Signage with enhanced color and sustainability benefits
From GlobeNewswire: 2025-01-12 08:00:00 E Ink to Showcase E Ink Spectra™ 6 Full-Color ePaper Retail Signage at NRF 2025 in